DK0587554T3 - Podofyllotoksinpræparat indeholdende triglycerider - Google Patents

Podofyllotoksinpræparat indeholdende triglycerider

Info

Publication number
DK0587554T3
DK0587554T3 DK90911870.5T DK90911870T DK0587554T3 DK 0587554 T3 DK0587554 T3 DK 0587554T3 DK 90911870 T DK90911870 T DK 90911870T DK 0587554 T3 DK0587554 T3 DK 0587554T3
Authority
DK
Denmark
Prior art keywords
preparation containing
containing triglycerides
podophyllotoxin
podophyllotoxin preparation
triglycerides
Prior art date
Application number
DK90911870.5T
Other languages
English (en)
Inventor
Kurt Leander
Jan Gunzinger
Boerje Rosen
Original Assignee
Analytecon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Analytecon Sa filed Critical Analytecon Sa
Application granted granted Critical
Publication of DK0587554T3 publication Critical patent/DK0587554T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK90911870.5T 1989-07-31 1990-07-17 Podofyllotoksinpræparat indeholdende triglycerider DK0587554T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902624A SE464167B (sv) 1989-07-31 1989-07-31 Topisk farmaceutisk beredning av podophyllotoxin

Publications (1)

Publication Number Publication Date
DK0587554T3 true DK0587554T3 (da) 1997-10-27

Family

ID=20376598

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90911870.5T DK0587554T3 (da) 1989-07-31 1990-07-17 Podofyllotoksinpræparat indeholdende triglycerider

Country Status (17)

Country Link
US (1) US6440428B1 (da)
EP (1) EP0587554B1 (da)
JP (1) JP3034026B2 (da)
KR (1) KR0145678B1 (da)
AT (1) ATE158948T1 (da)
AU (1) AU633949B2 (da)
CA (1) CA2064476C (da)
DE (1) DE69031569T2 (da)
DK (1) DK0587554T3 (da)
ES (1) ES2109237T3 (da)
FI (1) FI100769B (da)
GB (1) GB2250437B (da)
HU (1) HU207939B (da)
NO (1) NO179632C (da)
RU (1) RU2097032C1 (da)
SE (1) SE464167B (da)
WO (1) WO1991001717A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39494E1 (en) * 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
AU1761197A (en) 1997-02-14 1998-09-08 Elisabeth Streels Composition with base of coconut oil and its use
FI105152B (fi) 1998-07-17 2000-06-30 Eero Saarela Paikallinen kivunlievitysmenetelmä
SE0102168D0 (sv) * 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
ES2665342T3 (es) * 2004-03-15 2018-04-25 Meda Ab Formulaciones y métodos para modificadores de la respuesta inmune
CN100427082C (zh) * 2005-08-02 2008-10-22 盛华（广州）医药科技有限公司 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
US9592188B2 (en) 2014-05-22 2017-03-14 Yansong Liu Method of treating or reducing the severity of dermatological conditions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826845A (en) * 1969-02-08 1974-07-30 Sankyo Co Ointment base
DE2063896A1 (de) 1970-12-28 1972-07-20 Dynamit Nobel Ag, 5210 Troisdorf Salbengrundlagen auf der Basis von Triglyceriden gesättigter mittelkettiger Fettsäuren und Verfahren zu deren Herstellung
US4235889A (en) * 1979-04-25 1980-11-25 Pharmazeutische Fabrik Evers & Co. Therapeutic agent for the external treatment of psoriasis, tinea and eczemas
US4341783A (en) * 1980-07-31 1982-07-27 Lemmon Company Topical use of dyphylline and dyphylline containing compositions
IL65588A (en) * 1981-07-10 1985-04-30 Orion Yhtymae Oy Pharmaceutical compositions for the treatment of skin
GB8307614D0 (en) * 1983-03-18 1983-04-27 Pharma Medica As Treatment of genital warts
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
JPH0720966B2 (ja) 1984-12-28 1995-03-08 コンプハルム・エイビ− 製薬学的に活性な化合物を含有する病気治療剤
US4895727A (en) 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
US4751075A (en) * 1986-01-08 1988-06-14 Redken Laboratories, Inc. Anhydrous cosmetic compositions for thermal skin treatments
DE3603859A1 (de) * 1986-02-07 1987-08-13 Roehm Pharma Gmbh Abwaschbare topische zubereitung zur therapie der psoriasis
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US4994496A (en) * 1987-09-09 1991-02-19 Repasky Elizabeth A Use of milk globules as carriers for drugs
US5104656A (en) * 1989-06-16 1992-04-14 Seth Pyare L Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent

Also Published As

Publication number Publication date
ATE158948T1 (de) 1997-10-15
SE464167B (sv) 1991-03-18
FI100769B (fi) 1998-02-27
CA2064476A1 (en) 1991-02-01
GB2250437A (en) 1992-06-10
HU9200015D0 (en) 1992-03-30
EP0587554A1 (en) 1994-03-23
SE8902624D0 (sv) 1989-07-31
GB2250437B (en) 1993-05-26
FI920428A0 (fi) 1992-01-30
NO179632C (no) 1996-11-20
KR920703047A (ko) 1992-12-17
DE69031569D1 (de) 1997-11-13
JP3034026B2 (ja) 2000-04-17
EP0587554B1 (en) 1997-10-08
NO179632B (no) 1996-08-12
AU6061690A (en) 1991-03-11
HU207939B (en) 1993-07-28
DE69031569T2 (de) 1998-02-19
JPH05500661A (ja) 1993-02-12
NO920255D0 (no) 1992-01-20
KR0145678B1 (ko) 1998-08-17
WO1991001717A1 (en) 1991-02-21
AU633949B2 (en) 1993-02-11
SE8902624L (sv) 1991-02-01
NO920255L (no) 1992-01-20
GB9200158D0 (en) 1992-03-11
US6440428B1 (en) 2002-08-27
ES2109237T3 (es) 1998-01-16
RU2097032C1 (ru) 1997-11-27
CA2064476C (en) 2000-09-12
HUT58996A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
DE3875425T2 (de) Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
NO871408L (no) Forbedringer ved farmasoeytiske akseptable salter.
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ZA773259B (en) Improvements in or relating to methods for reducing the doses of biologically active substances while maintaining the biological effects
DK0587554T3 (da) Podofyllotoksinpræparat indeholdende triglycerider
IT8721691A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide, loro procedimento di preparazione e loro impiegocome sostanze medicinali.
ES2062145T3 (es) 1,8-naftiridinas substituidas.
DK116689D0 (da) Pyrroloquinolin- og pyrrolophenothiazin-carboxamider og beslaegtede forbindelser samt farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af laegemidler til behandling af inflammation eller andre prostaglandin- eller leukotrin-formidlede sygdomme
DE3268159D1 (en) Medicaments based on algae, and formulations thereof
IT7920786A0 (it) Derivati della n-fenil-alanina, loro preparazione e loro impiegocome prodotti medicinali.
FI851365A0 (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
DE3579074D1 (de) Verminderung der toxischen wirkungen von anthrachinon-medikamenten.
DE3877747T2 (de) Glasartige matrize zur verabreichung von heilmitteln.
NO169323C (no) Fremgangsmaate til fremstilling av en steril enhetsdoseform, av 7-(dimetylaminometylen)-amino-9a-metoksymitosan i glass
IT8721098A0 (it) Derivati della 1-benzene solfonil 2-oco 5-alchiltio pirrolidina, un loro procedimentodi preparazione e il loro impiegocome stostanze medicinali.
AU2790189A (en) Use of compounds of the retuline series as compounds with pharmaceutical activity, in particular analgesic, antispasmodic and antiinflammatory medicaments
AU2582588A (en) Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer
IT8523406A0 (it) Derivati della 1-benzensolfonil2-osso 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanze medicinali.
ATE97802T1 (de) Infusion sauerstoffreicher perfluorierter fluessigkeit im augapfel.
IT8520654A0 (it) Derivato della piridina ad azione terapeutica, in particolare antiflogistica, analgesica e antipiretica; procedimento per prepararlo, uso farmaceutico e composizioni farmaceutiche che lo contengono.
RO91652A2 (ro) Compozitie medicamentoasa pentru tratamentul unor dermatoze
IT8022114V0 (it) Siringa per l'iniezione di medicinali in soluzione da prepararsi al momento dell'uso.
DK163865C (da) Anvendelse af oestrogener til fremstilling af praeparater til lokal anvendelse til behandling af forhoejet tryk i oejet
IT7827747A0 (it) Processo per la preparazione di esteri non simmetrici di acidi 1,4-diidropiridin-dicarbossilici eloro impiego come farmaci.